All In Biotech

Free tool

FAERS Monitor: Livtencity

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 215596 or its brand name (Livtencity, Maribavir). Reports on generic versions are filed under their own applications.

Reports

2,469

Serious

2,128

86% of reports

Hospitalization

1,124

Death reported

536

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death317
  • dysgeusia268
  • taste disorder229
  • hospitalisation223
  • off label use206
  • cytomegalovirus infection189
  • drug ineffective187
  • drug resistance184
  • fatigue176
  • cytomegalovirus infection reactivation156
  • product use issue136
  • diarrhoea133
  • viral load increased128
  • nausea115
  • cytomegalovirus viraemia88

Reports by year received

View as table
YearReports
20121
20132
20152
20161
20172
201812
201911
20209
202117
2022497
2023514
2024563
2025556
2026282

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,690 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
cytomegalovirus infection reactivationSignal156311.8267.146,334
viral load increasedSignal128290.4244.635,429
cytomegalovirus viraemiaSignal88171.9139.714,492
cytomegalovirus infectionSignal18998.085.417,853
taste disorderSignal22997.285.921,493
drug resistanceSignal18461.553.410,817
dysgeusiaSignal26830.827.57,707
hospitalisationSignal22312.410.92,335
product use issueSignal1366.25.2589
deathSignal3173.12.8478
off label useSignal2062.01.8107
fatigue1761.91.780
diarrhoea1331.81.544
nausea1151.21.05
drug ineffective1871.21.17

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.